Elekta acquires Nucletron - MarketLine Financial Deals

Elekta acquires Nucletron

Elekta acquires Nucletron - MarketLine Financial Deals
Elekta acquires Nucletron
Published Sep 15, 2011
4 pages — Published Sep 15, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report


Elekta AB, a Sweden-based human care company focused on providing clinical solutions for treating cancer and brain disorders, has acquired Nucletron B.V., a Netherlands-based radiotherapy and medical device company, from AlpInvest Partners N.V., Advent International Corporation and other shareholders.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "Elekta acquires Nucletron" Sep 15, 2011. Alacra Store. Jun 20, 2018. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Elekta-acquires-Nucletron-2052-61588>
MarketLine Financial Deals. (2011). Elekta acquires Nucletron Sep 15, 2011. New York, NY: Alacra Store. Retrieved Jun 20, 2018 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Elekta-acquires-Nucletron-2052-61588>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.